MEDICAL ADVOCATES
 WOMEN AND HIV RESOURCE CENTER
  HIV Clinical Management
General Reports
ART Drugs
HAART
Diagnostics/Monitoring
Prophylaxis






 


 
Women abd HIV Main Page Main New and Noteworthy Home Page

Last Update:  May 15, 2012
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

General Reports
Additional HIV Management Reports are Indexed under Applicable National Web Pages
General Reports  

     Journal Papers, Abstracts, and Commentaries
 
 
A WEEK-IN-REVIEW FEATURED REPORT
FULL-TEXT PDF COMMENTARY
Asking the right questions: developing evidence-based strategies for treating HIV
in women and children
l Karim QA, Banegura A,  Cahn P,  et al
BMC Public Health 2011, 11:388
 Paper

Pill Taking From the Perspective of HIV-Infected Women Who Are Vulnerable to Antiretroviral Treatment Failure.
Stevens PE, Hildebrandt E.  
Qual Health Res. 2009 Mar 3
 Abstract
 
Gender differences in the diagnosis and treatment of HIV.
 Squires KE. 
Gend Med. 2007 Dec;4(4):294-307.
 Abstract

Women and human immunodeficiency virus: unique management issues.
Clark RA, Dumesre J.
Am J Med Sci. 2004 Jul;328(1):17-25.
 Abstract

Total Lymphocyte Count, Hemoglobin, and Delayed-Type Hypersensitivity as
Predictors of Death and AIDS Illness in HIV-1–Infected Women Receiving Highly
Active Antiretroviral Therapy.
Anastos K, Shi Q, French AL, et al
J Acquir Immune Defic Syndr. 2004 Apr 20;35(4):383-392.
 Abstract
ART Drugs

Efavirenz

     Journal Papers, Abstracts, and Commentaries
 
  Nevirapine versus efavirenz in 742 patients: no link of liver toxicity with female sex,
and a baseline CD4 cell count greater than 250 cells/mul
 Manfredi R, Calza L.  
AIDS. 2006 Nov 14;20(17):2233-2236.
Abstract
Etravirine
 
  Etravirine Concentrations in the Cervico-Vaginal Compartment in HIV-1 infected Women receiving
Etravirine-containing antiretroviral therapy: DIVA 02 study.
 Clavel C, Peytavin G, Tubiana R,  et al 
Antimicrob Agents Chemother. 2012 Apr 23.
 Abstract
 
     Conference Reports, Abstracts, and Posters
 
  Etravirine penetration in cervicovaginal compartment exceed the median inhibitory concentration
in HIV-1 infected women treated with etravirine-containing regimen (DIVA-02 study)
C. Clavel, G. Peytavin, R. Tubiana, et al
 (6th IAS Conference)
 Abstract
Nevirapine
 
     Journal Papers, Abstracts, and Commentaries
 
  Nevirapine (NVP) pharmacokinetics (PK) and risk of rash and hepatitis among HIV-infected Sub-Saharan
African Women.
 Dong BJ, Zheng Y, Hughes MD, et al
AIDS. 2012 Feb 1
 Abstract

Raltegravir

     Journal Papers, Abstracts, and Commentaries
 
  Raltegravir Concentrations in the Genital Tract of HIV-1 infected Women Treated with a
raltegravir containing Regimen : DIVA 01 study
Clavel C, Peytavin G, Tubiana R, et al
Antimicrob Agents Chemother. 2011 Mar 28.
Abstract
 
     Conference Reports, Abstracts, and Posters
 
  Raltegravir as replacement for PI- or NNRTI-based ART in HIV-infected women with lipohypertrophy: the women,
integrase, and fat accumulation trial
J. Lake, G.A. McComsey, T. Hulgan, et al
 (6th IAS Conference)
 Abstract
 
Saquinavir
 
     Journal Papers, Abstracts, and Commentaries
 
  Pharmacokinetic Study of Saquinavir 500 mg Plus Ritonavir (1000/100 mg Twice a Day) in
HIV-Positive Pregnant Women.
Martinez-Rebollar M, Lonca M, Perez I, et al
 Ther Drug Monit. 2011 Dec;33(6):772-7
 Abstract
Tenofovir
 
     Journal Papers, Abstracts, and Commentaries
 
  Simultaneous Delivery of Tenofovir and Acyclovir via an Intravaginal Ring.
 Moss JA, Malone AM, Smith TJ,  et al
Antimicrob Agents Chemother. 2011 Nov 28.
Abstract
 
Tenofovir/Emtricitabine
 
     Conference Reports, Abstracts, and Posters
 
  POSTER
Determination of Tenofovir and Emtricitabine Uptake in vitro Using Non-monocyctic
Female Genital Tract Cells
A  James, J King, I Ofotokun, et al
(19 CROI)
 PDF Poster     Abstract
HAART/ART
Additional HAART Reports are Indexed under Applicable National Web Pages
General Reports

    Journal Papers, Abstracts, and Commentaries
 
 
Associations of cardiovascular variables and HAART with cognition in middle-aged HIV-infected
and uninfected women.
Crystal HA, Weedon J, Holman S, et al
J Neurovirol. 2011 Oct 18
 Abstract

Lack of effect of compartmentalized drug resistance mutations on HIV-1 pol divergence
in antiretroviral-experienced women.
Kelley CF, Sullivan ST, Lennox JL, et al 
AIDS. 2010 Apr 12.
 Abstract

Treatment Responses in Antiretroviral Treatment-Naive Premenopausal and Postmenopausal
HIV-1-Infected Women: An Analysis from AIDS Clinical Trials Group Studies.
Patterson KB, Cohn SE, Uyanik J, et al
Clin Infect Dis. 2009 Jun 25
 Abstract

Nonnucleoside reverse transcriptase inhibitor pharmacokinetics in a large unselected cohort
of HIV-infected women.
Gandhi M, Benet LZ, Bacchetti P, et al 
J Acquir Immune Defic Syndr. 2009 Apr 15;50(5):482-91
 Abstract

Effects of HIV antiretrovirals on the pharmacokinetics of hormonal contraceptives.
 El-Ibiary SY, Cocohoba JM.
Eur J Contracept Reprod Health Care. 2008 Jun;13(2):123-32.
 Abstract
 
A WEEK-IN-REVIEW FEATURED REPORT
 Patterns, predictors, and consequences of initial regimen type among HIV-infected
women receiving highly active antiretroviral therapy.
 Golub ET, Benning L, Sharma A, et al
Clin Infect Dis. 2008 Jan 15;46(2):305-12
 Abstract
 
Consistency of Initial Antiretroviral Therapy With HIV Treatment Guidelines in a US Cohort of
HIV-Infected Women.
 Cocohoba J, Wang QJ, Cox C, et al
J Acquir Immune Defic Syndr. 2007 Dec 20
Abstract
 
FULL-TEXT PDF ARTICLE
 Assessing the effect of HAART on quality of life among HIV-infected women.
Liu C, Weber K, Robison E, Hu Z, et al 
AIDS Res Ther. 2006 Mar 20;3(1):6 [
 Paper
 
A WEEK-IN-REVIEW FEATURED REPORT
Factors Associated with Poor Immunologic Response to Virologic Suppression by Highly
Active Antiretroviral Therapy in HIV-Infected Women.
Vaamonde CM, Hoover DR, Anastos K, et al 
AIDS Res Hum Retroviruses. 2006 Mar;22(3):222-31.
 Abstract

Prevalence of clinical symptoms associated with highly active antiretroviral therapy in the
Women's Interagency HIV Study.
Silverberg MJ, Gore ME, French AL, et al
Clin Infect Dis. 2004 Sep 1;39(5):717-24
 Abstract
 
     Conference Reports, Abstracts, and Posters
 
 
Genital secretions of HIV-1 infected women on effective antiretroviral therapy contain high drug concentrations and low amounts of
cell-free virus
A. Sheth, T. Evans-Strickfaden, A. Martin, et al
 (6th IAS Conference)
 Abstract

POSTER
 Association between NVP Pharmacokinetics and Development of Rash and Hepatitis among
HIV-infected Sub-Saharan African Women in ACTG A5208
 B Dong, Z Zheng, M Hughes,  et al
 (18th CROI)
 PDF Poster     Abstract

POSTER
Identification of Novel Factors that Influence Atazanavir Exposure in a Diverse
Population of HIV-infected Women under Conditions of Actual Use
M Gandhi, S Gange, C Ponath, et al
(17th CROI)
 PDF Poster     Abstract

POSTER
Raltegravir Concentrations in the Cervicovaginal Compartment Exceed the Median I
nhibitory Concentration in HIV-1-infected Women Treated with a Raltegravir-containing
Regimen: DIVA 01 Study
C Clavel, L Mandelbrot, A-G Marcelin, , et al
(17th CROI)
PDF Poster     Abstract

POSTER
 Stavudine toxicity in women is the main reason for treatment change in a 3 year
prospective cohort of adult patients started on first line antiretroviral treatment (ART)
in Uganda
B. Castelnuovo, A. Kiragga, M. Kamya, et al
(5th IAS Conference)
 PDF Poster     Abstract

The association of perception of body fat changes with HAART adherence in the women’s
interagency HIV study
 Plankey M, Bacchetti P, Jin C, et al
 (4th IAS Conference)
 Abstract
 
Important Issues in the Treatment of HIV-infected Women: Optimizing ART throughout Life
S Lockman,  J Currier
 (14 CROI)
Abstract
 
Pharmacogenomics of HAART Metabolism and Transport: The Women's Interagency
HIV Study
C Pearce M Gandhi, S Gange, et al
(14 CROI)
Abstract 
 
Prevalence of Anemia among Women in a Trial of HAART including Zidovudine for PMTCT
in Kisumu, Kenya
T Thomas, R Masab, R Ndivo,
 (14 CROI)
Abstract 
 
Effectiveness of HAART on Quality Adjusted Life Years among HIV-infected Women
C Liu H Chu, E Robison, et al
 (13 CROI)
Abstract

Effect of depression on HAART initiation in a U.S. multisite cohort of HIV-positive women
J A Cook, J K Burke, D D Grey, M H Cohen, et al
 (15IAC)
 Abstract


Adherence   

          Journal Papers, Abstracts, and Commentaries

 
An investigation of the possible interaction between the use of Vitamin C and highly active antiretroviral therapy (HAART) adherence and effectiveness in treated HIV+ women.
Merenstein D, Wang C, Gandhi M, et al
Complement Ther Med. 2012 Aug;20(4):222-7
 Abstract

Recent Trauma is Associated with Antiretroviral Failure and HIV Transmission Risk Behavior Among
HIV-Positive Women and Female-Identified Transgenders.
Machtinger EL, Haberer JE, Wilson TC, Weiss DS.
AIDS Behav. 2012 Mar 17.
Abstract

Women and Vulnerability to HAART Non-Adherence: A Literature Review of Treatment Adherence by Gender from 2000 to 2011.
Puskas CM, Forrest JI, Parashar S, et al
Curr HIV/AIDS Rep. 2011 Oct 12
 Abstract

Association of Child Care Burden and Household Composition with Adherence to Highly Active
Antiretroviral Therapy in the Women's Interagency HIV Study.
 Merenstein D, Schneider MF, Cox C, et al
AIDS Patient Care STDS. 2009 Feb 25.
 Abstract
 
Association Between Living With Children and Adherence to Highly Active Antiretroviral Therapy
in the Women's Interagency HIV Study.
 Merenstein DJ, Schneider MF, Cox C, et al
Pediatrics. 2008 Apr;121(4):e787-93.
 Abstract
 
In or out? Methodological considerations for including and excluding findings from a
meta-analysis of predictors of antiretroviral adherence in HIV-positive women.
Voils CI, Barroso J, Hasselblad V, Sandelowski M. 
J Adv Nurs. 2007 Jun 3;
 Abstract

Illicit drug use, depression and their association with highly active antiretroviral therapy
in HIV-positive women.
Cook JA, Grey DD, Burke-Miller JK, et al
Drug Alcohol Depend. 2007 Feb 7;
 Abstract
 
Efficacy of a Group Medication Adherence Intervention Among HIV Positive Women:
The SMART/EST Women's Project
Jones DL, McPherson-Baker S
AIDS Behav. 2006 Sep 21
 Abstract
 
Sleep Disturbance and Depression as Barriers to Adherence.
 Phillips KD, Moneyham L, Murdaugh C, et al 
Clin Nurs Res. 2005 Aug;14(3):273-293.
 Abstract
 
Medication adherence for HIV positive women caring for children: in their own words.
Wood SA, Tobias C, McCree J.
AIDS Care. 2004 Sep;16(7):909-13.
Abstract
 
Adherence to antiretroviral medications in hiv/aids care: a narrative exploration of one
woman's foray into intentional nonadherence.
 Johnston Roberts K, Mann T.
Health Care Women Int. 2003 Jul-Aug;24(6):552-64.
Abstract

Home-based study of anti-HIV drug regimen adherence among HIV-infected women:
feasibility and preliminary results.
Durante AJ, Bova CA, Fennie KP, et al
 AIDS Care 2003 Feb;15(1):103-15
 Abstract

Maternal adherence to the zidovudine regimen for HIV-exposed infants to prevent HIV
|infection: a preliminary study.
 Demas PA, Webber MP, Schoenbaum EE, et al.
 Pediatrics 2002 Sep;110(3):e35
 Abstract

Adherence to antiretroviral therapy among women with HIV infection.
 Erlen JA, Sereika SM, Cook RL, Hunt SC.
 J Obstet Gynecol Neonatal Nurs 2002 Jul-Aug;31(4):470-7
 Abstract

Adherence discourse among African-American women taking HAART.
 Sankar A, Luborsky M, Schuman P, Roberts G.
 AIDS Care 2002 Apr;14(2):203-18
 Abstract

Adherence to antiretroviral therapy and its association with sexual behavior in a national
sample of women with human immunodeficiency virus.
 Wilson TE, Barron Y, Cohen M, et al.
 Clin Infect Dis 2002 Feb 15;34(4):529-34
 Abstract
 

  
     Conference Reports, Abstracts, and Posters
 
  Improved adherence to HAART among a cohort of non-pregnant women and its
associated factors
C D Zorrilla, L E Santiago, M Acevedo, et al
 (15IAC)
 Abstract
 
Using directly delivered therapy (DDT) to improve ART adherence among urban indigent women
M B Nykyforchyn, G Morgan, L Laufman, et al
(15IAC)
 Abstract
 
Resistance

    Journal Papers, Abstracts, and Commentaries
 
 
HIV-1 Drug Resistance in Variants from the Female Genital Tract and Plasma
Kemal KS, Burger H, Mayers D, et al 
J Infect Dis. 2007 Feb 15;195(4):535-45.
 Abstract
 
Genotypic Resistance and Immunologic Outcomes Among HIV-1-Infected Women With
Viral Failure.
 Gange SJ, Schneider MF, Grant RM, et al  
J Acquir Immune Defic Syndr. 2006 Jan 1;41(1):68-74.
Abstract

Differential evolution of cell-associated virus in blood and genital tract of HIV-infected
females undergoing HAART.
Tirado G, Jove G, Reyes E,, et al  
Rev Med SuVirology. 2005 Apr 10;334(2):299-305.
 Abstract
 
Treatment Discontinuation/Interruption

    Journal Papers, Abstracts, and Commentaries

  Factors and Temporal Trends Associated With Highly Active Antiretroviral Therapy
Discontinuation in the Women's Interagency HIV Study.
 Ahdieh-Grant L, Tarwater PM, Schneider MF, et al 
J Acquir Immune Defic Syndr. 2005 Apr 1;38(4):500-503.
Abstract

     Conference Reports, Abstracts, and Posters
 
  Prevalence and predictors of treatment interruptions in a longitudinal cohort study
in women
M Gandhi, N Ameli, T Liegler, R Grant, et al
(15IAC)
 Abstract
 
Adverse Events

    Journal Papers, Abstracts, and Commentaries
 
 
The Impact of Kidney Function at Highly Active Antiretroviral Therapy Initiation on Mortality in
HIV-Infected Women.
Estrella MM, Parekh RS, Abraham A,  et al
J Acquir Immune Defic Syndr. 2010 Jun 25
 Abstract

Effect of Non-Nucleoside Reverse Transcriptase Inhibitors on Cytokine, Chemokine,
and Immunoglobulin Profiles in Serum and Genital Secretions of HIV-Infected Women.
Sachdeva RK, Wanchu A, Bagga R, Malla N, Sharma M.
J Interferon Cytokine Res. 2010 Feb 28
 Abstract

Highly active antiretroviral therapy and incidence of cervical squamous
intraepithelial lesions among HIV-infected women with normal cytology
and CD4 counts above 350 cells/mm3.
 Sirera G, Videla S, López-Blázquez R, et al
J Antimicrob Chemother. 2007 Oct 31;
 Abstract

Antiretroviral Therapies Associated with Lipoatrophy in HIV-Infected Women.
Tien PC, Barron Y, Justman JE, et al
 AIDS Patient Care STDS. 2007 May;21(5):297-305
 Abstract
Diagnostics/Monitoring
     Journal Papers, Abstracts, and Commentaries
 
  Quantification of Genital HIV-1 DNA in Women with Low Plasma HIV-1 RNA Levels
Typical of HIV-1 Non-Transmitters.
Benki S, McClelland RS, Emery S, et al
J Clin Microbiol. 2006 Oct 18;
Abstract
Prophylaxis
     Conference Reports, Abstracts, and Posters
 
  First Dose and Steady-state Genital Tract Pharmacokinetics of Ten Antiretroviral Drugs in
HIV-infected Women: Implications for Pre- and Post- Exposure Prophylaxis
J Dumond, R Yeh, K Patterson, et al
 (12 CROI)
 Abstract

Women abd HIV Main Page Main New and Noteworthy Home Page

HIV Clinical Management